my community channel

Register to store your favourite programmes, receive schedule alerts, sign up for factsheets, participate in forums and much more...

DONATE

to a charity of your choice

What's On

Sun 14th Mar 2010
F	06:00	Being Breast Aware
F	06:25	Light Rain
F	06:30	Untold Stories
F	07:00	21st Century: Women
F	07:25	Media Box Shorts

full schedule

Home

Your Space

Squiffy's Space

This item viewed 2294 times

Other entries by Squiffy:

Results 1 - 5 of 382

About Squiffy

Webmaster and Discussion Board Administrator for the Multiple Sclerosis Resource Centre. http...

more...

Phase II trial Of Multiple-Sclerosis treatment CDP323 halted

Create new blog

Biogen Idec Inc. and Belgian biopharmaceutical company UCB SA discontinued a Phase II clinical trial of a treatment for relapsing-remitting multiple sclerosis, saying there was no clinically relevant benefit for patients.

The companies said a preliminary interim analysis showed patients enrolled in the clinical trial didn't benefit as expected from the treatment, CDP323, compared with placebo after a six-month treatment period.

Source: Biogen Idec Inc. & UCB SA (01/07/09)

Comments

There are no comments currently....

You must login to leave comments...

Last Updated ( Wednesday, 01 July 2009 )

back to Your Charity Space

donate

send us feedback